Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METR-NK cells in advanced ovarian cancer
NCT06395844Phase 2Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of METR-NK cells in ovarian cancer, sponsored by Anhui Provincial Tumor Hospital. Started May 2024; status: recruiting.
02
Drugs
METR-NK cells
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT06395844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06395844.